Results 181 to 190 of about 93,748 (310)

Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. [PDF]

open access: bronze, 1980
Lawrence J. Beilin   +8 more
openalex   +1 more source

Efficacy and Tolerability of Metyrapone in Mild Autonomous Cortisol Secretion: Real‐World Findings From Clinical Practice

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Mild autonomous cortisol secretion (MACS) is associated with increased cardiometabolic risk factors including hypertension, type 2 diabetes and dyslipidaemia. By using evening doses of metyrapone, a short‐acting 11‐β hydroxylase inhibitor, it has been shown that it is possible to reset the abnormal circadian cortisol rhythm in MACS ...
Simon Berry   +3 more
wiley   +1 more source

Clinical and Radiographic Performance of Two Distinct Sandblasted, Large‐Grit, Acid‐Etched Implant Surfaces: A Split‐Mouth Randomized Clinical Trial

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Aim To compare the clinical performance of two sandblasted, large‐grit, acid‐etched implant surfaces regarding changes in radiographic marginal bone level (MBL) 12 months after loading. Materials and Methods In this randomized, split‐mouth, dual‐center clinical trial, each patient received one test (modified hydrophilic surface) implant and ...
Blanca Vílchez   +7 more
wiley   +1 more source

Effect of interdisciplinary obesity care on metabolic markers and body weight in people with type 2 diabetes in a rural setting: A randomised controlled trial

open access: yesClinical Obesity, Volume 15, Issue 2, April 2025.
Summary Management of type 2 diabetes includes medications that can unintentionally increase obesity and insulin resistance. This unblinded, single‐centre, randomised controlled trial focused on rural Australian adults with type 2 diabetes (aged 18–75 and body mass index [BMI] >30 kg/m2), measuring the effectiveness of a tailored interdisciplinary ...
Giuliana O. Murfet   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy